Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today ...
Creative Biolabs announced enhanced support for brain-immune-gut (BIG) axis regulation research, combining advanced gut ...
Study in highly translatable non-human primate models demonstrate how selective PKA-II modulation in combination with levodopa improved motor ...
Background Pancreatic ductal adenocarcinoma (PDAC) remains one of the most lethal cancers due to its aggressive biology and ...
Heart failure affects men and women differently — in pathophysiology, clinical presentation, treatment response, and long-term outcomes — yet sex and gender ...
Cognito Therapeutics, a clinical-stage neurotechnology company developing novel therapies for neurodegenerative disorders, ...
Researchers developed a microscopic theory in which intra-valley, finite-momentum pair-density waves generate the Kekulé ...
Two experiments designed to detect signals directly found no evidence for the signal reported by an earlier experiment.
Consider a neural implant dubbed the Microscale Optoelectronic Tetherless Electrode, or MOTE, developed at Cornell University ...
The race for 6G wireless data has just achieved a major speed limit. Japanese rsearchers have developed a new microcomb-driven terahertz (THz) wireless communication system that achieves data rates up ...
Last month we discussed how all interconnects will be optical in the data center in five years, but that’s only part of the story. Every optical interconnect needs a laser. The laser provides the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results